P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY
Главные авторы: | Rafat Abonour, Robert Rifkin, Sikander Ailawadhi, Hans C. Lee, Christina Gasparetto, Lynne Wagner, Brian Durie, James Hardin, Howard Terebelo, Mohit Narang, Kathleen Toomey, Yuexin Tang, Sujith Dhanasiri, Jasmeet Anand, Edward Yu, Thomas Marshall, Liang Liu, Sundar Jagannath |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Wiley
2023-08-01
|
Серии: | HemaSphere |
Online-ссылка: | http://journals.lww.com/10.1097/01.HS9.0000970564.52503.e2 |
Схожие документы
-
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
по: Sikander Ailawadhi, и др.
Опубликовано: (2024-11-01) -
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry
по: Hans C. Lee, и др.
Опубликовано: (2021-07-01) -
Connect MM Registry as a national reference for United States multiple myeloma patients
по: Sikander Ailawadhi, и др.
Опубликовано: (2020-01-01) -
Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
по: Sundar Jagannath, и др.
Опубликовано: (2018-07-01) -
Lenalidomide-Associated ITP
по: Christina I. Herold, и др.
Опубликовано: (2011-01-01)